Clinical Trials
99 trialsKCC-S
University of Utah
Study of Kidney Tumors in Younger Patients
Children's Oncology Group
Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response
University Health Network, Toronto
FRISC
Centre Hospitalier Universitaire, Amiens
Risk of Scrotal Hydroceles After Nephrectomy For Kidney Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
KIDCaD
Charles University, Czech Republic
A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).
Pfizer
IMPLICATION
Centre Hospitalier Universitaire de Besancon
GenCInibs-Suni
Centre Hospitalier Universitaire de Nīmes
Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy
H. Lee Moffitt Cancer Center and Research Institute
Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation
University of Texas Southwestern Medical Center
DELFI-L101
Delfi Diagnostics Inc.
PRIORITY
Institut Bergonié
Genomic Testing and Resulting Medical Decisions
Arbeitsgemeinschaft medikamentoese Tumortherapie
SOGUGCOVID
Spanish Oncology Genito-Urinary Group
CRYO-BO-2021
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Clinical-pathological Characterization and Outcomes of Renal Cell Carcinoma in Latin American
Latin American Cooperative Oncology Group
CP-Renal
University Hospital, Strasbourg, France
ROOT
Taproot Health
REMEDY
University Health Network, Toronto
A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland.
Pfizer
RADIANT
DxTerity Diagnostics
Rib Removal and Pain in Partial Nephrectomy
TC Erciyes University
Risk-based Screen and Prognostic Analysis for Second Primary Malignancies in Kidney Cancer Patients
Peking University First Hospital
Treatment Patterns With Targeted Therapies In Mrcc In Sweden - A Retrospective Analysis Of Data From National Registries
Pfizer
Novel Prognostic Markers in Renal Cancer
Royal Marsden NHS Foundation Trust
BANN
University Medical Center Groningen
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
Optimization of Management for Sporadic Bilateral Renal Cell Carcinoma
Peking University First Hospital
LiVHOU
University Hospital, Strasbourg, France
Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma
University of Nebraska
A Prospective Post-Market Study to Evaluate the Clinical Utility of IRIS, a Three-dimensional (3-D) Anatomical Modeling Software for Pre-operative Surgical Planning and Intra-operative Navigation for Nephrectomy
Intuitive Surgical
Gag-layer in the Urothelium of the Human Upper Urinary Tract
Aarhus University Hospital
Assessment of Complications in Patients Who Underwent LPN According to the CCI
Samsun Liv Hospital
Three-dimensional Virtual Imaging to Improve the Accuracy of Standard CT-based Nephrometric Scores: a Prospective Multicentric Observational Study
San Luigi Gonzaga Hospital
Safety and Effectiveness of Nivolumab in Recurring Kidney Cancer Participants
Bristol-Myers Squibb
The Association of Marital Status With Kidney Cancer Surgery Morbidity
Beijing Tsinghua Chang Gung Hospital
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Exact Sciences Corporation
IMEPOCA
Nantes University Hospital
Participant Reported Outcomes and Treatment Experiences in Kidney Cancer
Bristol-Myers Squibb
DOSTILCU
Aesculap AG
ADOPT
University of Dundee
A Study to Observe the Onset of Immune-related Adverse Reactions in Patients With Non-surgical or Renal Cell Carcinoma (RCC) That Has Spread
Bristol-Myers Squibb
Complications Associated With Partial Nephrectomy for Renal Cancer
Central Hospital, Nancy, France
To Establish a Reproducible Organoid Culture Model With Human Kidney Cancer
Chinese University of Hong Kong
IMPACT-RCC
Radboud University Medical Center
écoREIN
Central Hospital, Nancy, France
Cellular Immunity and Renal Cell Cancer
Clinical Hospital Center Rijeka
LPN in Patients With High-complex Renal Tumors
Samsun Liv Hospital
Active Surveillance of the Small Renal Mass
Yale University